These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18546200)

  • 1. Evaluation of substrates for 90 degrees peel adhesion--a collaborative study. II. Transdermal drug delivery systems.
    Wokovich AM; Brown SA; Shen M; Doub WH; Cai B; Sadrieh N; Chen ML; Machado S; Buhse LF
    J Biomed Mater Res B Appl Biomater; 2009 Jan; 88(1):61-5. PubMed ID: 18546200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of substrates for 90 degrees peel adhesion--a collaborative study. I. Medical tapes.
    Wokovich AM; Brown SA; McMaster FJ; Doub WH; Cai B; Sadrieh N; Chen ML; Machado S; Shen M; Buhse LF
    J Biomed Mater Res B Appl Biomater; 2008 Oct; 87(1):105-13. PubMed ID: 18386842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesive backing foil interactions affecting the elasticity, adhesion strength of laminates, and how to interpret these properties of branded transdermal patches.
    Fauth C; Wiedersberg S; Neubert RH; Dittgen M
    Drug Dev Ind Pharm; 2002 Nov; 28(10):1251-9. PubMed ID: 12476871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release liner removal method for transdermal drug delivery systems (TDDS).
    Wokovich AM; Shen M; Doub WH; Machado SG; Buhse LF
    J Pharm Sci; 2010 Jul; 99(7):3177-87. PubMed ID: 20135693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiments on peeling adhesive tapes from human forearms.
    Karwoski AC; Plaut RH
    Skin Res Technol; 2004 Nov; 10(4):271-7. PubMed ID: 15536659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and in vitro evaluation of new drug-in-adhesive formulations of fentanyl transdermal patches.
    Mehdizadeh A; Toliate T; Rouini MR; Abashzadeh S; Dorkoosh F
    Acta Pharm; 2004 Dec; 54(4):301-17. PubMed ID: 15634614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic selection criteria for safety and patient benefit [X]: Water-vapor permeability and peel force properties of brand-name and generic ketoprofen tapes.
    Nozawa M; Goto M; Wada Y; Ishii F; Shimokawa KI
    Drug Discov Ther; 2021 May; 15(2):87-92. PubMed ID: 33952778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal delivery of fentanyl from matrix and reservoir systems: effect of heat and compromised skin.
    Prodduturi S; Sadrieh N; Wokovich AM; Doub WH; Westenberger BJ; Buhse L
    J Pharm Sci; 2010 May; 99(5):2357-66. PubMed ID: 19967778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro efficacy and release study with anti-inflammatory drugs incorporated in adhesive transdermal drug delivery systems.
    Meyer S; Peters N; Mann T; Wolber R; Pörtner R; Nierle J
    J Pharm Sci; 2014 Apr; 103(4):1142-8. PubMed ID: 24633817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin hypersensitivity reactions to transdermal therapeutic systems--still an important clinical problem.
    Jenerowicz D; Polańska A; Olek-Hrab K; Silny W
    Ginekol Pol; 2012 Jan; 83(1):46-50. PubMed ID: 22384639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion testing of polyurethane matrix patches for transdermal delivery of testosterone.
    Dittgen M; Gansen P
    Pharmazie; 2012 Jun; 67(6):567-8. PubMed ID: 22822549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of current transdermal drug delivery systems: a retrospective evaluation.
    Berba J; Banakar U
    Am Pharm; 1990 Nov; NS30(11):33-7, 40-1. PubMed ID: 2124411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro evaluation of a new fentanyl patch based on functional and non-functional pressure sensitive adhesives.
    Taghizadeh SM; Soroushnia A; Mohamadnia F
    AAPS PharmSciTech; 2010 Mar; 11(1):278-84. PubMed ID: 20182829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal fentanyl in childhood and adolescence: a comprehensive literature review.
    Zernikow B; Michel E; Anderson B
    J Pain; 2007 Mar; 8(3):187-207. PubMed ID: 17350554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of adhesive properties of patches based on acrylic matrices.
    Minghetti P; Cilurzo F; Montanari L
    Drug Dev Ind Pharm; 1999 Jan; 25(1):1-6. PubMed ID: 10028412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the pharmacokinetics of 17 beta-estradiol after a single 4-day application of Oesclim 50, Oesclim 100, and Vivelle 0.05 (Menorest 50) transdermal delivery systems.
    Guichard JP; Sauron R; Jones AB
    J Clin Pharmacol; 1999 Aug; 39(8):811-6. PubMed ID: 10434233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transdermal delivery of fentanyl.
    Lane ME
    Eur J Pharm Biopharm; 2013 Aug; 84(3):449-55. PubMed ID: 23419814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the local tolerability and adhesion of a new matrix system (Menorest) for estradiol delivery with an established transdermal membrane system (Estraderm TTS).
    Erianne JA; Winter L
    Maturitas; 1997 Mar; 26(2):95-101. PubMed ID: 9089558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence performances of pressure sensitive adhesives on a model viscoelastic synthetic film: a tool for the understanding of adhesion on the human skin.
    Renvoise J; Burlot D; Marin G; Derail C
    Int J Pharm; 2009 Feb; 368(1-2):83-8. PubMed ID: 18992309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating elevated release liner adhesion of a transdermal drug delivery system (TDDS): a study of Daytrana™ methylphenidate transdermal system.
    Wokovich AM; Shen M; Doub WH; Machado SG; Buhse LF
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1217-24. PubMed ID: 21438703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.